FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE and COUGH

3,317 reports of this reaction

3.8% of all FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE reports

#4 most reported adverse reaction

Overview

COUGH is the #4 most commonly reported adverse reaction for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, manufactured by GlaxoSmithKline LLC. There are 3,317 FDA adverse event reports linking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE to COUGH. This represents approximately 3.8% of all 88,399 adverse event reports for this drug.

Patients taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH3,317 of 88,399 reports

COUGH is moderately reported among FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

In addition to cough, the following adverse reactions have been reported for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE:

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

0XYGENACETAMINOPHEN 325 MGACETAMINOPHEN 325MGACETAMINOPHEN 500 MGACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCLACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETIC ACID

Frequently Asked Questions

Does FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE cause COUGH?

COUGH has been reported as an adverse event in 3,317 FDA reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

COUGH accounts for approximately 3.8% of all adverse event reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, making it a notable side effect.

What should I do if I experience COUGH while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

If you experience cough while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE Full ProfileAll Drugs Causing COUGHGlaxoSmithKline LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.